Artelo Biosciences Performance
The firm shows a Beta (market volatility) of 0.0, which signifies not very significant fluctuations relative to the market. the returns on MARKET and Artelo Biosciences are completely uncorrelated.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Artelo Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable essential indicators, Artelo Biosciences is not utilizing all of its potentials. The recent stock price fuss, may contribute to near-short-term losses for the sophisticated investors. ...more
| Begin Period Cash Flow | 12.2 M |
Artelo |
Artelo Biosciences Relative Risk vs. Return Landscape
If you would invest (100.00) in Artelo Biosciences on November 29, 2024 and sell it today you would earn a total of 100.00 from holding Artelo Biosciences or generate -100.0% return on investment over 90 days. Artelo Biosciences is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded stocks are less volatile than Artelo, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Artelo Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Artelo Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Artelo Biosciences, and traders can use it to determine the average amount a Artelo Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| ARTLW |
Based on monthly moving average Artelo Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Artelo Biosciences by adding Artelo Biosciences to a well-diversified portfolio.
Artelo Biosciences Fundamentals Growth
Artelo Stock prices reflect investors' perceptions of the future prospects and financial health of Artelo Biosciences, and Artelo Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Artelo Stock performance.
| Return On Equity | -0.71 | |||
| Return On Asset | -0.44 | |||
| Shares Outstanding | 2.33 M | |||
| EBITDA | (10.29 M) | |||
| Cash And Equivalents | 457.33 K | |||
| Cash Per Share | 0.23 X | |||
| Total Debt | 63 K | |||
| Book Value Per Share | (0.35) X | |||
| Cash Flow From Operations | (8.01 M) | |||
| Earnings Per Share | (1.43) X | |||
| Total Asset | 20.42 M | |||
| Retained Earnings | (31.02 M) | |||
Things to note about Artelo Biosciences performance evaluation
Checking the ongoing alerts about Artelo Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Artelo Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Artelo Biosciences is not yet fully synchronised with the market data | |
| Artelo Biosciences has some characteristics of a very speculative penny stock | |
| Artelo Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Artelo Biosciences has accumulated 63 K in total debt. Artelo Biosciences has a current ratio of 0.4, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Artelo Biosciences' use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (10.08 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Artelo Biosciences has accumulated about 457.33 K in cash with (8.01 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23. |
- Analyzing Artelo Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Artelo Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Artelo Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Artelo Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Artelo Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Artelo Biosciences' stock. These opinions can provide insight into Artelo Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Artelo Stock
If you are still planning to invest in Artelo Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Artelo Biosciences' history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |